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Abstract Objective: To identify
and summarize characteristics of
computerized decision-support sys-
tems (CDSS) for tight glycemic
control (TGC) and to review their
effects on the quality of the TGC
process in critically ill patients.
Methods: We searched Medline
(1950–2008) and included studies on
critically ill adult patients that repor-
ted original data from a clinical trial
or observational study with a main
objective of evaluating a given TGC
protocol with a CDSS.
Results: Seventeen articles met the
inclusion criteria. Eleven out of sev-
enteen studies evaluated the effect of
a new TGC protocol that was intro-
duced simultaneously with a CDSS
implementation. Most of the reported
CDSSs were stand-alone, were not
integrated in any other clinical infor-
mation systems and used the
‘‘passive’’ mode requiring the clini-
cian to ask for advice. Different
implementation sites, target users,
and time of advice were used,
depending on local circumstances.
All controlled studies reported on at
least one quality indicator of the
blood glucose regulatory process that
was improved by introducing the
CDSS. Nine out of ten controlled
studies either did not report on the
number of hypoglycemia events (one
study), or reported on no change (six
studies) or even a reduction in this
number (two studies).
Conclusions: While most studies
evaluating the effect of CDSS on the
quality of the TGC process found
improvement when evaluated on the
basis of the quality indicators used, it
is impossible to deﬁne the exact suc-
cess factors, because of simultaneous
implementation of the CDSS with a
new or modiﬁed TGC protocol and
the hybrid solutions used to integrate
the CDSS into the clinical workﬂow.
Keywords Systematic review 
Tight glycemic control  Insulin 
Computerized decision-support
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Introduction
Blood glucose control aiming at normoglycemia (i.e.,
blood glucose levels 80–110 mg/dl), frequently referred
to as ‘‘tight glycemic control’’, has been shown to reduce
mortality and morbidity of critically ill patients [1, 2]
although its implementation bears the risk of hypoglyce-
mia [1, 2]. Applying tight glycemic control (TGC),
however, requires additional efforts, especially from the
nursing staff who are expected to adhere to the TGC
protocol. Such protocols are often complex, requiring
speciﬁc timing of blood glucose level (BGL) measure-
ments, and the availability of patient-speciﬁc data. One
way to support nurses in adhering to protocols is by
applying information technology, in particular clinical
computerized decision-support systems (CDSSs).
Intensive Care Med (2009) 35:1505–1517
DOI 10.1007/s00134-009-1542-0 REVIEWIn general, a CDSS is a computer program that is
intended to help healthcare workers in making decisions
[3]. A CDSS can be characterized by the level of sup-
port, the consultation mode, and the communication
style. The level of support ranges from general to
patient-speciﬁc: e.g., from merely displaying the proto-
col chart to suggesting the speciﬁc amount of insulin to
be administered. Some systems are passive, providing
advice only on demand, whereas others are active,
providing feedback to the healthcare worker without
being asked for it. Finally, regardless of the level of
support and the consultation mode, a CDSS may operate
in two communication styles: in the critiquing mode the
system provides advice which is dependent on the
adherence of clinical practice to a protocol (e.g., noti-
fying the nurse that a BGL measurement has been
expected but not performed), in the non-critiquing mode
it provides advice regardless of whether a protocol is
followed or not [4]. Notwithstanding the potential ben-
eﬁts of CDSSs, issues pertaining to their design,
implementation, evaluation, and to critical success fac-
tors, are largely still open. Glucose regulation is
speciﬁcally interesting as it forms an application in
which a CDSS is applied in a highly controlled clinical
practice. Therefore lessons learned from glucose regu-
lation CDSSs can be used for other highly controlled
clinical practices, for example mechanical ventilation
and blood-pressure control.
The objective of this systematic review is to identify
and summarize characteristics of CDSSs and to review
their effects on the quality of the TGC process in pub-
lished studies on the use of CDSS in TGC for critically ill
patients.
Methods
We searched for relevant English language articles based
on keywords in title, abstract and MeSH terms, using
Ovid Medline and Ovid Medline In-Process (1950 to
December 31, 2008). The ﬁnal literature search was
performed on January 11, 2008.
Figure 1 shows the applied search strategies and the
corresponding search ﬂowchart. In the ﬁrst stage (A),
we searched for terms related to glucose and insulin. In
the second stage (B) we limited the search using the
terms ‘‘critical illness’’ or ‘‘critical care’’ or ‘‘intensive
care’’. In the third stage (C), keywords and MeSH
terms referring to a decision-support system were
searched. The results of these three stages were com-
bined using the Boolean operator ‘‘AND’’. Searching
was supplemented by scanning bibliographies from
identiﬁed articles.
Two reviewers independently examined all titles and
abstracts. Discrepancies among the two reviewers were
resolved by consensus involving a third reviewer. Arti-
cles were selected if they reported original data from a
clinical trial or observational study on critically ill adult
patients and only if one of their main objectives con-
cerned the evaluation of a given TGC protocol with a
CDSS. A study was included if the TGC protocol
implied an upper normoglycemia limit of, at most,
150 mg/dl. Opinion papers, surveys, and letters were
excluded.
From the selected papers, the same two reviewers
extracted data on the following items:
1 method and study design aspects;
2 CDSS characteristics;
3 TGC quality indicators in terms of their deﬁnition and
applicability; and
4 data on the effect of the CDSS on the quality of the
TGC process or mortality or morbidity.
A quality indicator was deﬁned as a measurable
quantity of the TGC process that may, alone or in com-
bination with other quantities, indicate some aspect of its
quality. Discrepancies between the two reviewers were
again resolved by consensus after involving the same
third reviewer.
To obtain insight into the heterogeneous nature of
these evaluation studies and according to the hierarchy of
study designs developed by the University of California
San Francisco Stanford Evidence-Based Practice Center
we classiﬁed the studies into:
Fig. 1 The search strategies applied and the search ﬂowchart. The
bold terms are MeSH terms
1506– randomized controlled trial (level I),
– non-randomized controlled trial (level II),
– observational study with controls (level III), and
– observational study without controls (level IV) [5, 6].
Results
Searching the online databases resulted in 70 articles. Ini-
tial screening of titles and abstracts rendered 21 articles
eligible for further full-text review. One additional article
was identiﬁed by reviewing bibliographies, yielding a total
of 22 articles. Based on the full text review, ﬁve studies
were excluded because they turned out not to address a
computerized system, leaving 17 articles for detailed
analysis.
Table 1 lists the materials (included patients and study
locations), TGC target range, design, and results of these
17 studies. Table 2 summarizes the CDSSs’ characteris-
tics. Table 3 reports all the used quality indicators of the
TGC process.
Methods and study design aspects
There were three randomized clinical trials, seven con-
trolled before/after trials, and seven observational studies.
Intwostudiesonlyinformationwasgivenonhowoftenthe
CDSS was used, in one of these studies this information
was only given for the three months after the study period.
In only one study the same TGC protocol was used
before and after the implementation of CDSS. In ﬁve
other studies a modiﬁed version of the TGC protocol was
used after the implementation of the CDSS. Two of these
ﬁve studies evaluated the same CDSS and the protocol
used, but in another setting. Eleven out of seventeen
studies evaluated the effect of a new TGC protocol
introduced at the same time with the implementation of
the CDSS. Three of these eleven studies also evaluated
the same CDSS and the protocol in different settings.
CDSS characteristics
MostofthereportedCDSSs(14outof17)werestand-alone
and were not integrated in other clinical information sys-
tems, for example computerized physician order entry
systems, patient data management systems, or intelligent
pumps. CDSSs in all studies were ‘‘patient speciﬁc’’ and
operated in the ‘‘critiquing’’ mode. This means that deci-
sion support was given if clinical practice for a patient was
not according to the protocol. Reminders on the time of the
next BGL measurement were ‘‘active’’ in nine out of sev-
enteenstudies.‘‘Active’’meansthattheusersautomatically
received the reminder without manually asking for it.
Support for insulin pump speed was ‘‘active’’ in one study
only; the others used the ‘‘passive’’ mode for pump
adjustments requiring the clinician to ask for advice.
In ﬁve studies the protocols were based on ‘‘if–then’’
statements on a sliding scale. They contained a list of
simple rules, with a condition (the ‘‘if’’ part) and a con-
clusion part (the ‘‘then’’ part). The condition was based on
thevalueofthecurrentBGLmeasurement.Theconclusion
speciﬁed the corresponding insulin amount (or insulin
pump speed) and the time interval until the next BGL
measurement. In the other 12 studies the protocols were
formula-based. Formula-based protocols rely on an famil-
iar and simple equation: insulin dose/hour = [BGL - 60]
9 multiplier(insulinsensitivity)[7],whichwassometimes
adapted. In this group of studies, a default number for the
multiplier was considered as the starting point for TGC.
Based on the latest BGL values and a statistical model, the
multiplier was recalculated and these values were used to
calculate the required next pump speed.
In most studies (14 out of 17), users manually entered
the BGL values and pump speeds into a separate CDSS
database, because these data were not electronically
available or they were not connected to the CDSS. In
three other studies these data were electronically retrieved
from a laboratory or a hospital information system.
Quality indicators
Twenty-four different indicators of glycemic control were
extracted(Table 3).Hypoglycemia-relatedindicatorswere
used in 14/17 studies as a proxy for safety. Six different
thresholds varying between 40 and 70 mg/dl were used to
deﬁne a hypoglycemia event. The most often used indi-
cators were BGL summaries such as mean or median BGL
(15/17 studies), the number of measurements in a prede-
ﬁned target range (10/17), the frequency of BGL
measurements (9/17), the time needed to reach the deﬁned
BGL target (8/17), the time spent in the predeﬁned BGL
range (7/17), or compliance to protocol (6/17). Hypergly-
cemia-related indicators (number of hyperglycemia events
and hyperglycemia index) (6/17) were other frequently
used indicators. Because of different target ranges, com-
paring these indicators is difﬁcult. Lower limits of target
ranges varied from 80 to 100 mg/dl. Similarly, the upper
limits of target ranges varied from 110 to 150 mg/dl.
Effect of the CDSS on the quality of the TGC process
All controlled studies reported on at least one quality
indicator that was improved by introducing the CDSS
(with or without the new protocol). Among controlled
studies, one study reported that the number of hypogly-
cemia events increased, but without mentioning whether































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1513Table 3 List of quality indicators used
Indicator Measurement description Refs.
Blood glucose levels
over a time period
Represented as mean and/or median BGL values. Each BGL




Mean or median BGL was also calculated in the morning (6:00–12:00,
morning BGL) [11], after the target range was achieved [10], after





Represented as the number or percentage of measurements in a
predeﬁned BGL range during the study, after the target is achieved
[10] or among early, on time, or late measurements (based on
protocol) [17].
Ten articles [9–11, 15,
17, 22, 24, 25, 27, 28]




Represented as: mean or median per patient [9, 22, 25, 28] or per
patient treatment day [15–17, 28]; mean sampling interval (time) [9,
17, 23, 29]; frequency overall [24] per day [15]; and mean number
of measurements before ﬁrst in-range BGL [22]
Nine articles [9, 15–17,
22–25, 28, 29]
Time to capture deﬁned
blood glucose target
Represented as mean and median of time or by Kaplan–Meier curve
[10, 25]
Eight articles [7, 9, 10,
16, 17, 22, 24, 25]
Time in predeﬁned range Represented as mean of percentage of time per patient [15, 24],
median of percentage of time per patient [16, 17, 29], or
cumulatively for all patients [8, 17, 25]
Seven articles [8, 15–17,
24, 25, 29]
Protocol compliance A comparison of measurement times suggested by protocol to actual
times of measurements and/or pump speed suggested by protocol to
actual pump speed during TGC or at the time of hypoglycemia
events.
Six articles [8, 9, 17, 22,
23, 29]
Hyperglycemic index Represented as median area between glucose–time curve and upper
normal range divided by time per patient during the trial. Upper
ranges were 110 [23], 117 [16], 120 [25], and 135 [17].
Four articles [16, 17, 23,
25]
Hyperglycemia events Represented as: percentage of measurements[180
a [25] or percentage
of time[150 [9, 25, 29] and percentage of measurements and
patients with at least one BGL[180 for more than 2 h [29]
Three articles [9, 25, 29]
Number of patients who
achieved predeﬁned
range
Represented as number and percentage of patients who achieved the
target range overall [22], within 12 and 24 h after starting IIT [9].
Two articles [9, 22]
BGL change over time Represented as BGL change in ﬁrst 24 h. One article [16]
BGL variability Represented as standard deviation of all measurements per patient. One article [17]
Number of patients who
did not achieve
predeﬁned range
Represented as number and percentage. One article [25]
Odds ratio of achieving
certain BGL
Per additional IC day and per used drugs. One article [11]
Time until ﬁrst BGL Represented as mean of time [16]. One article [15, 16]
Time until starting IIT Proportion of patients per time [15]. One article [15, 16]
Hypoglycemia-related indicator (proxy for safety)
Hypoglycemia events \40 [7, 9, 15, 22, 23, 25, 27], B40 [9, 22, 25, 28],\50 [7, 10, 11, 26],
\60 [7, 24], and\70 [25] were used as thresholds for deﬁning a
BGL as hypoglycemia event.




\40 [16, 17] and B40 [15, 16, 29] were used to deﬁne a BGL as
severe hypoglycemia event. In one study clinical ﬁndings deﬁned
severe hypoglycemia [7]




\63 was used deﬁne a BGL as a mild hypoglycemia event. Two article [16, 17]
Next BGL after
hypoglycemia
Represented as mean BGL. Two articles [7, 10]
Time until next in
predeﬁned range after
hypoglycemia
Represent as mean time. Two articles [7, 10]
Need for glucose injection \40 have to inject and\72 should be considered. One article [27]
Time until hypoglycemia
recognition
Represented as maximum time until hypoglycemia recognition. One article [7]
Time until next BGL after
hypoglycemia
Represented as mean time. One article [10]
a Unit of all BGL thresholds is mg/dl
1514controlled studies one study did not report [8], six studies
reported no change, and two studies [9, 10] even reported
a reduction in the number of hypoglycemia events. Seven
observational studies also reported that the number of
hypoglycemia events was in an acceptable range. No
clinical symptoms attributable to hypoglycemia were
reported in any of the studies. The observational studies
also used efﬁciency-related indicators, for example mean
BGL or time to capture TGC in the acceptable range by
introducing the CDSS (with or without a new protocol).
Discussion and recommendations
In this review we have summarized the design, charac-
teristics, indicators, results, and limitations of 17
published studies on glucose regulation CDSSs in inten-
sive care. Although most studies reported a positive effect
on at least one quality indicator the diversity of studies in
term of case-mix, insulin therapy, associated therapies,
and indicators used (varying in their deﬁnition and the
ways of calculating them) severely hamper comparison of
the studies. Therefore, although meta-analysis is theoret-
ically possible, the results will not be reliable. In addition
only three papers reported on an RCT. Our search
included all synonyms known to us of TGC, for example
‘‘intensive insulin therapy’’ (IIT). A limitation of our
search is that we only addressed studies whose main
objective concerned evaluation of a given TGC protocol
with a CDSS; we might have missed some studies with a
limited evaluation and TGC quality measurement focus.
The implementation of paper-based TGC protocols
with decision tables or charts for adjusting the insulin rate
is cumbersome and time-consuming [11]. Although for
many studies without CDSS implementation results were
acceptable [12, 13], frequent measurements are crucial in
TGC. Furthermore, a paper-based TGC protocol cannot
remind the users about the time for the next measurement.
For these reasons, CDSSs may improve glycemic control
and help implementing TGC. To the best of our knowl-
edge this is the ﬁrst review exclusively dedicated to
supporting the TGC protocol with a CDSS. Existing
reviews on TGC focused on the range of TGC, the effects,
and advantages, regardless of the implementation strategy
of the TGC protocol, such as a CDSS [12, 13]. The
remainder of this section will discuss the ﬁndings on
study design, CDSS characteristics, and TGC quality
indicators and will provide recommendations on these
subjects for future research.
Study design
Most of the studies used a before–after design and
introduced the CDSS together with a new protocol.
Therefore, it is difﬁcult to conclude that the CDSS itself
was the causative reason for observed improvements in
glucose regulation. The fact that in some studies the users
differed before and after the introduction of the CDSS
(based on a new protocol) further hampers identiﬁcation
of success factors for improved glucose regulation. Future
research should carefully choose a study design in order
to clearly separate the effect of the TGC protocol and the
contribution of the CDSS.
CDSS characteristics
ToachievetheoptimumeffectofTGC,theprotocolshould




the computerized physician order entry (CPOE) as the
starting point and integrated the CDSS into this. They
believe this provided a ‘‘one stop shop’’ by capturing BGL
and other patient data from the clinician at the bedside,
generating new orders, and logging the data into the elec-
tronic medical record. Clinicians should ﬁrst initiate an
order in the CPOE before the CDSS could generate advice.
Both pump adjustment and next measurement time
reminders were passive. In contrast, Vogelzang et al. [16,
17] believe that because most nurses spend some time near
the glucose analyzer until the result of the analysis is
known,acomputersituated nexttotheanalyzer is theideal
spot for the system to interact with the nurses. This system
generated an active reminder but it could be shown only
when nurses were near the analyzer, missing other clini-
cians.Asaﬁnalexample,Roodetal.[8]evaluatedasystem
which got the necessary data from a patient data-manage-
ment system (PDMS), generating reminders during care at
the bedside computer, and logging the data into the elec-
tronic medical record. This system provided an active
reminderbutitisunknownwhathappenswithareminderif
the user was logged out or was away from the computer.
Altogether more research is necessary to investigate the
mostappropriate implementationsite,target user,and time






deﬁnitions among the studies although they are all meant to
measure the same underlying concept. For example the
sampling frequency of measurements plays a crucial role in
TGC but it was reported in nine out of 17 studies. In these
nine articles, six different ways were used to calculate the
1515sampling frequency (e.g., mean or median per patient or per
patient treatment day or mean sampling interval). Thus
reproducibility and comparability of research results are
hampered by this lack of unambiguous deﬁnitions. The
choice of quality indicators used was not explicitly men-
tionedinanyofthestudies.Wecouldnotﬁndanassociation
betweenindicatorselectionandpatientpopulation,diseases,
or speciﬁcation of the designed protocols.
Because hypoglycemia is the main risk of TGC
implementation, almost all studies reported on at least one
indicator related to hypoglycemia. The number of hypo-
glycemic events before and after TGC implementation
and/or the management of these events form the main
safety-related indicators of TGC. However, we found
several deﬁnitions and ambiguous terminology for ren-
dering a BGL measurement (or a set thereof) as a
hypoglycemic event. Most of the studies reported no
change or even a reduction in the number of hypoglyce-
mia events. This ﬁnding is in contrast with some studies,
including a recent meta-analysis [18], showing that TGC
implementation increased the risk of hypoglycemia
events. TGC, semantically, excludes the occurrence of
hypos because it is ‘‘tight’’. Thus, if one is applying a
TGC protocol but hypoglycemia occur then the culprit
resides in the implementation of the regulatory process.
CDSSs are used to improve adherence to TGC protocols;
therefore, if the protocol is sound a CDSS contributes to
keeping BGL in range and hence to reducing the risk of
hyperglycemia and hypoglycemia.
The strong relationship between hyperglycemia and
mortality and morbidity is well known from the literature.
Hence hyperglycemia reduction is the main objective of
TGC. Surprisingly, only six studies explicitly deﬁned a
hyperglycemic event and/or hyperglycemia index, but
they used different deﬁnitions of such an event.
The increased number of blood-glucose measure-
ments, especially in well regulated patients, may increase
the number of measurements with low glucose levels and
may thus reduce the mean and median plasma glucose
level of the whole group, giving a false impression of
improvement of the studies.
There is almost no literature that compares different
glycemic metrics to relevant clinical outcomes, such as
severity-associated mortality [19]. It is, therefore, hard to
evaluate and qualify these indicators. Deciding upon a
common glycemic vocabulary is hence essential.
Applying the results of highly controlled clinical trials
like those evaluating TGC to everyday practice is difﬁcult
[20]. The need for frequent measurements and pump
adjustments increases the need for CDSSs. If a passive
CDSS is implemented, we cannot be sure that the users
ask for support on time. In such a case usage of the system
(frequency) should be clearly described. If an active
CDSS is implemented based on the content of these
highly controlled protocols, the reminders will be shown
many times. Showing many pop-up reminders usually
irritates users, resulting in the alerts being ignored [5, 6].
Also, in an active CDSS it is not clear how many times
the messages are actually seen on time and not too late,
because of users being logged off or away from the
computer. Therefore, in future research it is necessary to
report the usage, usability, and satisfaction with such
CDSSs.
Data veriﬁcation is very important, especially when
the values are entered manually in information systems.
Button et al. [21] implemented double data entry as a
data-veriﬁcation tool. Morris et al. [22] mentioned this
issue, although they did not implement any data veriﬁ-
cation techniques. They are of the opinion that enabling
bedside nurses to use CDSS with minimum effort out-
weigh the theoretical advantage of additional security and
double data entry. Similar to others, in their study the
accuracy of manually entered values and the possibility of
introducing new kind of errors were not reported or dis-
cussed. Using CDSSs without a data-veriﬁcation process
might be a critical safety issue and hence authors ought to
address this issue when discussing their results.
Conclusion
While most studies evaluating the effect of CDSS on the
quality of the TGC process found improvement when
evaluated on the basis of the quality indicators used, it is
impossible to deﬁne the exact success factors. This is
mainly because of the lack of standard agreed-upon
indicators of glycemic control, the simultaneous imple-
mentation of the CDSSs with new treatment protocols,
and the various solutions used for integrating the CDSS
into the users’ workﬂow. This systematic review provided
key recommendations and information for researchers and
ICU managers who want to develop and evaluate CDSSs
for glucose regulation or other highly controlled clinical
practices.
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